Are you interested in the latest advances in Parkinson's disease treatment? Here are some key points from my knowledge base:

- New Medications: Recent approvals include
- Xadago (safinamide) in 2017
- Inbrija (levodopa inhalation powder) in 2018
- Nourianz (istradefylline) in 2019
- Kynmobi (apomorphine sublingual Show Full Answer

Are you interested in the latest advances in Parkinson's disease treatment? Here are some key points from my knowledge base:

- New Medications: Recent approvals include:
- Xadago (safinamide) in 2017
- Inbrija (levodopa inhalation powder) in 2018
- Nourianz (istradefylline) in 2019
- Kynmobi (apomorphine sublingual film) in 2020
- Ongentys (opicapone) in 2020
- Gocovri for "off" episodes and dyskinesia in 2021

- Clinical Trials: Participation in clinical trials can help pave the way for more treatment options.

- Nonmotor Symptoms: Focus on treating cognitive changes, hallucinations, and delusions with medications like Nuplazid (pimavanserin).

For more detailed information, you can visit the source: [MyParkinsonsTeam](https://www.MyParkinsonsTeam.com/resources/park...).

 This AI-generated response comes from MyParkinsonsTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

4 Parkinson’s Advances: How Research Is Improving Treatment | MyParkinsonsTeam

The History of Parkinson’s Disease | MyParkinsonsTeam